MA
AGN

Montag & Associates’s Allergan plc AGN Stock Holding History

Montag & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,345
Closed -$257K – 314
2019
Q4 		$257K Buy
+1,345
New +$243K 0.02% 273
2019
Q2 		– Sell
-3,973
Closed -$582K – 319
2019
Q1 		$582K Sell
3,973
-2,171
-35% -$315K 0.05% 212
2018
Q4 		$821K Sell
6,144
-9,755
-61% -$1.6M 0.09% 160
2018
Q3 		$3.03M Buy
+15,899
New +$2.92M 0.27% 90
2017
Q2 		– Sell
-1,520
Closed -$363K – 247
2017
Q1 		$363K Sell
1,520
-1,000
-40% -$233K 0.04% 199
2016
Q4 		$529K Buy
+2,520
New +$522K 0.06% 176

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Montag & Associates's AGN Position: Q1 2020 in Review

Montag & Associates sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,345 shares — an estimated $257K sold.

Montag & Associates first reported a position in AGN in Q4 2016 and held it in 6 quarters. The position peaked at $3.03M in Q3 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Montag & Associates reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Montag & Associates sold 1,345 Allergan plc shares in Q1 2020, an estimated $257K.
  • Montag & Associates first reported a position in Allergan plc in Q4 2016 and held it in 6 quarters.
  • Montag & Associates's Allergan plc position peaked at $3.03M in Q3 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Montag & Associates's 13F filing for Q1 2020, filed 6 May 2020.